Pandorum Technologies has announced a strategic partnership with Nucelion Therapeutics, a Hyderabad-based company, to expand manufacturing and supply capabilities for exosome-based regenerative therapies across the Asia-Pacific (APAC) region. The collaboration is centered on ophthalmology, where demand for restorative treatments is rising, and will focus on scaling production, strengthening quality systems, and preparing for clinical development … Pandorum Partners With Nucelion to Scale Exosome-Based Eye Therapies Across Asia-Pacific Read More » To access this post, you must purchase Individual Subscriber Yearly or Enterprise Subscriber.